Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Health › AstraZeneca holds talks with Bristol Myers Squibb on...
Health

AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger

The Guardian Business Monday 03 August 2026, 07:08 UTC By Julia Kollewe 1 min read
Key Points

Tie-up would be one of the biggest pharmaceutical deals ever and create the world’s fourth-largest drugmaker Business live – latest updatesBritain’s biggest drugmaker AstraZeneca is in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group. AstraZeneca, run by longtime chief executive Pascal Soriot, is the second-biggest listed company in the UK, with a market value of nearly £196bn. BMS, headquartered in Princeton...

Tie-up would be one of the biggest pharmaceutical deals ever and create the world’s fourth-largest drugmaker

Britain’s biggest drugmaker AstraZeneca is in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group.

AstraZeneca, run by longtime chief executive Pascal Soriot, is the second-biggest listed company in the UK, with a market value of nearly £196bn. BMS, headquartered in Princeton and known for its cancer treatments, is worth $133bn.

Continue reading...
AstraZeneca (ORG) Bristol Myers Squibb (ORG) US (LOCATION) Pascal Soriot (PERSON) UK (LOCATION) BMS (ORG) Princeton (LOCATION)
Originally published by The Guardian Business Read original →

Related Stories

Calls for investigation into practice of keeping patients in SA hospital corridors

The SA nurses' union is calling for a SafeWork SA investigation into what it says is a growing practice of keeping patients in hospital corridors during times of high demand. The call followed the death of a woman who became unresponsive while on a bed in a corridor at the Royal Adelaide Hospital last year. SA health minister Blair Boyer said the practice emerged in response to coronial recommendations into three ramping-related deaths The South Australian nurses' union wants the state...

ABC Australia 56m ago

AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger

Tie-up would be one of the biggest pharmaceutical deals ever and create the world’s fourth-largest drugmaker Business live – latest updatesBritain’s biggest drugmaker AstraZeneca is in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group. AstraZeneca, run by longtime chief executive Pascal Soriot, is the second-biggest listed company in the UK, with a market value of nearly £196bn. BMS, headquartered in Princeton...

The Guardian World 1h ago

AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger

Tie-up would be one of the biggest pharmaceutical deals ever and create the world’s fourth-largest drugmaker Business live – latest updatesBritain’s biggest drugmaker AstraZeneca is in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group. AstraZeneca, run by longtime chief executive Pascal Soriot, is the second-biggest listed company in the UK, with a market value of nearly £196bn. BMS, headquartered in Princeton...

The Guardian UK 1h ago

Battling depression, 40-year-old psychiatrist jumps to death in Ghaziabad

GHAZIABAD: A 40-year-old psychiatrist allegedly died by suicide after jumping from the fifth floor of her apartment in Ghaziabad, Uttar Pradesh, police said on Monday. The woman, identified as Dr Hemika Agrawal, allegedly jumped from her flat in Officers City-2 Society in the Raj Nagar Extension area on Sunday. She was taken to a hospital, where doctors declared her dead.

Times of India 1h ago